Cargando…
A mixed-method comparison of physician-reported beliefs about and barriers to treatment with medications for opioid use disorder
BACKGROUND: Evidence demonstrates that medications for treating opioid use disorder (MOUD) —namely buprenorphine, methadone, and extended-release naltrexone—are effective at treating opioid use disorder (OUD) and reducing associated harms. However, MOUDs are heavily underutilized, largely due to the...
Autores principales: | Haffajee, Rebecca L., Andraka-Christou, Barbara, Attermann, Jeremy, Cupito, Anna, Buche, Jessica, Beck, Angela J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491096/ https://www.ncbi.nlm.nih.gov/pubmed/32928272 http://dx.doi.org/10.1186/s13011-020-00312-3 |
Ejemplares similares
-
Perceptions of buprenorphine barriers and efficacy among nurse practitioners and physician assistants
por: Andraka-Christou, Barbara, et al.
Publicado: (2022) -
Comparison of Rural vs Urban Direct-to-Physician Commercial Promotion of Medications for Treating Opioid Use Disorder
por: Nguyen, Thuy, et al.
Publicado: (2019) -
Barriers to medications for opioid use disorder in the court system: provider availability, provider “trustworthiness,” and cost
por: Ahmed, Fatema Z., et al.
Publicado: (2022) -
Psychiatric Co-Morbidities in Pregnant Women with Opioid Use Disorders: Prevalence, Impact, and Implications for Treatment
por: Arnaudo, Camila L., et al.
Publicado: (2017) -
An Analysis of Primary Care Clinician Communication About Risk,
Benefits, and Goals Related to Chronic Opioid Therapy
por: Danielson, Elizabeth C., et al.
Publicado: (2019)